Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Abraxane in Metastatic Breast Cancer in a Real-life Setting

NCT02555696 is registered in ClinicalTrials.gov with Celgene as lead sponsor.

NCT NCT02555696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02555696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Abraxane in Metastatic Breast Cancer in a Real-life Setting
Lead sponsor
Celgene
Phase
Observational
Overall status
Completed
Start date
May 31, 2012
Completion date
December 31, 2016
Enrollment
203 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer